Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Sanofi
Company Monitoring Page for Sanofi
latest headlines for company on cafepharma
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A
,
biotech
,
Amylyx Pharmaceuticals
,
Arena Pharmaceuticals
,
AstraZeneca
,
Aurinia Pharmaceuticals
,
Biogen
,
Biohaven
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
Merck
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Sanofi
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says
Fierce Pharma
Thu, 01/13/22 - 11:06 am
Tags:
JPMHC 2022
,
Novartis
,
Leqvio
,
drug launches
,
Regeneron
,
Amgen
,
Sanofi
Sanofi makes $75M preclinical bet to join Roche, Novartis and more in congested Parkinson's field
Fierce Biotech
Wed, 01/12/22 - 11:19 pm
Tags:
Sanofi
,
ABL Bio
,
Parkinson's Disease
,
ABL301
JPM 2022: Sanofi has designs on creating Big Pharma's 'strongest' immunology franchise, CFO says
Fierce Pharma
Tue, 01/11/22 - 10:18 pm
Tags:
Sanofi
,
JPMHC 2022
,
M&A
,
Paul Hudson
JPM22, Day 2: Sanofi's dealmaking priorities, bluebird's gene therapy goals and more
Fierce Pharma
Tue, 01/11/22 - 11:37 am
Tags:
JPMHC 2022
,
GSK
,
Sanofi
,
Bluebird Bio
Sanofi makes AI play, putting up $100M and billions in biobucks to form broad deal with Exscientia
Fierce Biotech
Fri, 01/7/22 - 10:37 am
Tags:
Sanofi
,
R&D
,
artificial intelligence
,
Exscientia
Sanofi cuts ties with Sangamo, sharpening focus on 'off-the-shelf' cell therapy
BioPharma Dive
Thu, 01/6/22 - 12:39 pm
Tags:
Sanofi
,
Sangamo Therapeutics
,
cell therapy
,
sickle cell disease
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
Tags:
clinical trials
,
Pfizer
,
Arena Pharmaceuticals
,
etrasimod
,
Sanofi
,
GSK
,
vaccines
,
COVID-19
,
Roche
,
gantenerumab
,
AbbVie
,
Gilead Sciences
,
Trodelvy
,
Karuna Therapeutics
,
KarXT
,
Intercept Pharma
,
obeticholic acid
,
Allogene
,
ALLO-501a
Leo puts target on Dupixent in US as FDA clears tralokinumab
Pharmaforum
Thu, 12/30/21 - 10:45 am
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
tralokinumab
,
FDA
2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in
Fierce Pharma
Wed, 12/22/21 - 11:37 pm
Tags:
COVID-19
,
pandemic
,
remote work
,
Sanofi
,
Biogen
,
Pfizer
,
Novartis
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay
Fierce Pharma
Wed, 12/22/21 - 11:11 am
Tags:
Takeda
,
Eohilia
,
Sanofi
,
Dupixent
,
FDA
,
eosinophilic esophagitis
Sanofi buys US immuno-oncology biotech Amunix for $1 billion
Pharmaforum
Tue, 12/21/21 - 10:36 am
Tags:
Sanofi
,
M&A
,
Amunix
,
immuno-oncology
,
cancer
,
solid tumors
,
oncology
Positive booster data for Sanofi/GSK COVID-19 vaccine
Biopharma Reporter
Wed, 12/15/21 - 10:48 am
Tags:
Sanofi
,
GSK
,
vaccines
,
COVID-19
,
boosters
Sanofi, Regeneron plot Dupixent filing in young eczema patients, advancing drug's megablockbuster ambitions
Fierce Pharma
Mon, 12/13/21 - 11:04 am
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
eczema
,
pediatric
2021: the year mRNA therapeutics came of age
Pharmaforum
Mon, 12/13/21 - 10:55 am
Tags:
MRNA
,
vaccines
,
COVID-19
,
Sanofi
,
AstraZeneca
,
Moderna Therapeutics
,
Pfizer
,
BioNTech
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
Fierce Pharma
Sun, 12/12/21 - 11:33 pm
Tags:
ASH2021
,
Sanofi
,
JNJ
,
Sarclisa
,
Darzalex
,
Multiple Myeloma
Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most
Stat
Wed, 12/8/21 - 11:45 pm
Tags:
Sanofi
,
Regeneron
,
asthma
,
pediatric
,
COVID-19
,
clinical trial diversity
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender list
Fierce Pharma
Sun, 12/5/21 - 10:45 pm
Tags:
Sanofi
,
Regeneron
,
Dupixent
,
DTC advertising
,
television ads
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
Thu, 12/2/21 - 10:57 am
Tags:
JNJ
,
Sanofi
,
Multiple Myeloma
,
Sarclisa
,
Kyprolis
,
Darzalex
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Wed, 12/1/21 - 11:46 pm
Tags:
Sanofi
,
vaccines
,
RSV
,
Flu
,
MRNA
,
pneumococcal disease
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.